Publication:
Non-alcoholic fatty liver in hereditary fructose intolerance.

No Thumbnail Available

Date

2019-02-15

Authors

Aldámiz-Echevarría, Luis
de Las Heras, Javier
Couce, María Luz
Alcalde, Carlos
Vitoria, Isidro
Bueno, María
Blasco-Alonso, Javier
Concepción García, María
Ruiz, Mónica
Suárez, Rafael

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by fat accumulation affecting >5% of the liver volume that is not explained by alcohol abuse. It is known that fructose gives rise to NAFLD and it has been recently described that the ingestion of fructose in low amounts in aldolase B deficient mice is associated with the development of fatty liver. Therefore, it is reasonable that patients with HFI (Hereditary Fructose Intolerance) present fatty liver at diagnosis, but its prevalence in patients treated and with adequate follow-up is not well documented in the literature. The aim of this study is to analyze the association between HFI and NAFLD in treated patients. A cross-sectional observational study was conducted. The population comprised 16 genetically diagnosed HFI patients aged from 3 years to 48 and in dietary treatment of fructose, sorbitol and sacarose exclusion at least for two years. Blood samples were obtained for analytical studies and anthropometric measurements of each patient were performed. Patients presented a Body Mass Index (BMI) of 17.9 ± 2.9 kg/m2. The HOMA index and Quick index were in normal range for our population. The S-adenosyl-methionine (SAM)/S-adenosyl-l-homocysteine (SAH) ratio was increased in the patients in whom this analysis was performed. By imaging techniques it was observed that 9 of the 16 patients presented fatty liver (7 by hepatic MRI). Of these 9 patients, only 3 presented hepatomegaly. 7 of 9 patients affected by the c.448G > C mutation had fatty infiltration, of which three of them presented in addition hepatomegaly. There is a high prevalence of fatty liver in HFI patients and it is not related to obesity and insulin resistance. The diagnosis of fatty liver in HFI patients and, above all, the identification of new therapeutic approaches, can positively impact the quality of life of these patients.

Description

MeSH Terms

Adolescent
Adult
Child
Child, Preschool
Cross-Sectional Studies
Female
Fructose Intolerance
Humans
Liver
Magnetic Resonance Imaging
Male
Middle Aged
Non-alcoholic Fatty Liver Disease
Young Adult

DeCS Terms

CIE Terms

Keywords

ALDOB gene, Hereditary fructose intolerance, Mutation, Non-alcoholic fatty liver disease

Citation